These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26990867)

  • 1. The Effect of Vaginal Oestriol Cream on Subjective and Objective Symptoms of Stress Urinary Incontinence and Vaginal Atrophy: An International Multi-Centre Pilot Study.
    Weber MA; Lim V; Oryszczyn J; Te West N; Souget J; Jeffery S; Roovers JP; Moore KH
    Gynecol Obstet Invest; 2017; 82(1):15-21. PubMed ID: 26990867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of 12 weeks of estriol cream on stress urinary incontinence post-menopause: A prospective multinational observational study.
    Te West NID; Harris K; Jeffrey S; de Nie I; Parkin K; Roovers JP; Moore KH
    Neurourol Urodyn; 2023 Apr; 42(4):799-806. PubMed ID: 36840920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study.
    Cano A; Estévez J; Usandizaga R; Gallo JL; Guinot M; Delgado JL; Castellanos E; Moral E; Nieto C; del Prado JM; Ferrer J
    Menopause; 2012 Oct; 19(10):1130-9. PubMed ID: 22914208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life and sexual function of naturally postmenopausal women on an ultralow-concentration estriol vaginal gel.
    Caruso S; Cianci S; Amore FF; Ventura B; Bambili E; Spadola S; Cianci A
    Menopause; 2016 Jan; 23(1):47-54. PubMed ID: 26079974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women.
    Dessole S; Rubattu G; Ambrosini G; Gallo O; Capobianco G; Cherchi PL; Marci R; Cosmi E
    Menopause; 2004; 11(1):49-56. PubMed ID: 14716182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is vaginal hyaluronic acid as effective as vaginal estriol for vaginal dryness relief?
    Stute P
    Arch Gynecol Obstet; 2013 Dec; 288(6):1199-201. PubMed ID: 24178484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ultrasound imaging of the lower urinary tract in post-menopausal women with urinary stress or combined type of incontinence before and after intravaginal administration of estriol].
    Martan A; Masata J; Halaska M; Voigt R
    Ceska Gynekol; 1999 Jan; 64(1):6-9. PubMed ID: 10377583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy.
    Barentsen R; van de Weijer PH; Schram JH
    Eur J Obstet Gynecol Reprod Biol; 1997 Jan; 71(1):73-80. PubMed ID: 9031963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vaginal estriol administration in treatment of postmenopausal urinary incontinence].
    Schmidbauer CP
    Urologe A; 1992 Nov; 31(6):384-9. PubMed ID: 1462489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-Dose Intravaginal Estriol and Pelvic Floor Rehabilitation in Post-Menopausal Stress Urinary Incontinence.
    Castellani D; Saldutto P; Galica V; Pace G; Biferi D; Paradiso Galatioto G; Vicentini C
    Urol Int; 2015; 95(4):417-21. PubMed ID: 26043913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oestradiol-releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms.
    Lose G; Englev E
    BJOG; 2000 Aug; 107(8):1029-34. PubMed ID: 10955437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcutaneous Temperature Controlled Radiofrequency (TTCRF) for the Treatment of Menopausal Vaginal/Genitourinary Symptoms.
    Leibaschoff G; Izasa PG; Cardona JL; Miklos JR; Moore RD
    Surg Technol Int; 2016 Oct; 29():149-159. PubMed ID: 27608749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal hormone-free moisturising cream is not inferior to an estriol cream for treating symptoms of vulvovaginal atrophy: Prospective, randomised study.
    Garcia de Arriba S; Grüntkemeier L; Häuser M; May TW; Masur C; Stute P
    PLoS One; 2022; 17(5):e0266633. PubMed ID: 35551533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultralow 0.03 mg vaginal estriol in postmenopausal women who underwent surgical treatment for stress urinary incontinence: effects on quality of life and sexual function.
    Caruso S; Cianci A; Sarpietro G; Matarazzo MG; Panella M; Cianci S
    Menopause; 2020 Feb; 27(2):162-169. PubMed ID: 31834156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
    Palacios S; Castelo-Branco C; Cancelo MJ; Vázquez F
    Maturitas; 2005 Feb; 50(2):98-104. PubMed ID: 15653006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of non-hormonal remedies for vaginal dryness: open, prospective, randomized trial.
    Stute P; May TW; Masur C; Schmidts-Winkler IM
    Climacteric; 2015; 18(4):582-9. PubMed ID: 25845406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom.
    Archer DF; Kimble TD; Lin FDY; Battucci S; Sniukiene V; Liu JH
    J Womens Health (Larchmt); 2018 Mar; 27(3):231-237. PubMed ID: 29193980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple therapy with Lactobacilli acidophili, estriol plus pelvic floor rehabilitation for symptoms of urogenital aging in postmenopausal women.
    Capobianco G; Wenger JM; Meloni GB; Dessole M; Cherchi PL; Dessole S
    Arch Gynecol Obstet; 2014 Mar; 289(3):601-8. PubMed ID: 24057079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ultralow topical estriol dose on vaginal health and quality of life in postmenopausal women who underwent surgical treatment for pelvic organ prolapse.
    Caruso S; Cianci S; Vitale SG; Matarazzo MG; Amore FF; Cianci A
    Menopause; 2017 Aug; 24(8):900-907. PubMed ID: 28350758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose estriol pessaries for the treatment of vaginal atrophy: a double-blind placebo-controlled trial investigating the efficacy of pessaries containing 0.2mg and 0.03mg estriol.
    Griesser H; Skonietzki S; Fischer T; Fielder K; Suesskind M
    Maturitas; 2012 Apr; 71(4):360-8. PubMed ID: 22285095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.